'If Grandma Is on the Table, No One Will Blink at the Price': A Former Drug Company Manager Explains Industry Price-Setting

The observations from an insider about the random process of pricing Xigris is consistent with investigations into the opaque world of setting the price for monopoly-protected medicines sold to customers whose lives may depend on them. (Photo: iStock/shironosov)